Header

UZH-Logo

Maintenance Infos

Browse by Creators

Navigate back| Up a level
Export as
Number of items: 14.

Gerstenberg, M; Theodoridou, A; Traber-Walker, N; Franscini, M; Wotruba, D; Metzler, S; Müller, M; Dvorsky, D; Correll, C U; Walitza, S; Rössler, W; Heekeren, K (2016). Adolescents and adults at clinical high-risk for psychosis: age-related differences in attenuated positive symptoms syndrome prevalence and entanglement with basic symptoms. Psychological Medicine, 46(05):1069-1078.

Metzler, S; Dvorsky, D; Wyss, C; Müller, M; Gerstenberg, M; Traber-Walker, N; Walitza, S; Theodoridou, A; Rössler, W; Heekeren, K (2015). Changes in neurocognitive functioning during transition to manifest disease: comparison of individuals at risk for schizophrenic and bipolar affective psychoses. Psychological Medicine, 45(10):2123-2134.

Wotruba, D; Heekeren, K; Michels, Lars; Buechler, R; Simon, J J; Theodoridou, A; Kollias, S; Rössler, W; Kaiser, S (2014). Symptom dimensions are associated with reward processing in unmedicated persons at risk for psychosis. Frontiers in Behavioral Neuroscience:8:382.

Wotruba, D; Michels, Lars; Buechler, R; Metzler, S; Theodoridou, A; Gerstenberg, M; Walitza, S; Kollias, S; Rossler, W; Heekeren, K (2014). Aberrant coupling within and across the default mode, task-positive, and salience network in subjects at risk for psychosis. Schizophrenia Bulletin, 40(5):1095-1104.

Metzler, S; Dvorsky, D; Wyss, C; Müller, M; Traber-Walker, N; Walitza, S; Theodoridou, A; Rössler, W; Heekeren, K (2014). Neurocognitive profiles in help-seeking individuals: comparison of risk for psychosis and bipolar disorder criteria. Psychological Medicine, 44(16):3543-3555.

Kohl, S; Heekeren, K; Klosterkötter, J; Kuhn, J (2013). Prepulse inhibition in psychiatric disorders – Apart from schizophrenia. Journal of Psychiatric Research, 47(4):445-452.

Hitz, K; Heekeren, K; Obermann, C; Huber, T; Juckel, G; Kawohl, W (2012). Examination of the effect of acute levodopa administration on the loudness dependence of auditory evoked potentials (LDAEP) in humans. Psychopharmacology, 221(3):389-396.

Heekeren, K; Rössler, W (2012). Was ist möglich mit Früherkennung und Frühintervention? Pro Mente Sana aktuell, (4):10-11.

Mutschler, J; Grosshans, M; Herwig, U; Heekeren, K; Kawohl, W; Brühl, A (2011). Pregabalin-induced suicidal ideations. Pharmacopsychiatry, 44(3):119.

Kaiser, S; Heekeren, K; Simon, J J (2011). The negative symptoms of Schizophrenia: Category or continuum? Psychopathology, 44(6):345-353.

Heekeren, K. Störungen der frühen Informationsverarbeitung in genuinen und experimentellen Psychosen. 2010, University of Zurich, Faculty of Medicine.

Schnell, K; Heekeren, K; Daumann, J; Schnell, T; Schnitker, R; Möller-Hartmann, W; Gouzoulis-Mayfrank, E (2008). Correlation of passivity symptoms and dysfunctional visuomotor action monitoring in psychosis. Brain: A Journal of Neurology, 131(10):2783-2797.

Heekeren, K; Daumann, J; Neukirch, A; Stock, C; Kawohl, W; Norra, C; Waberski, T D; Gouzoulis-Mayfrank, E (2008). Mismatch negativity generation in the human 5HT2A agonist and NMDA antagonist model of psychosis. Psychopharmacology, 199(1):77-88.

Daumann, J; Fischermann, T; Heekeren, K; Henke, K; Thron, A; Gouzoulis-Mayfrank, E (2005). Memory-related hippocampal dysfunction in poly-drug ecstasy (3,4-methylenedioxymethamphetamine) users. Psychopharmacology, 180(4):607-611.

This list was generated on Tue Apr 24 20:40:04 2018 CEST.